Advanced search
Publication Cover
Clinical Ophthalmology Volume 18, 2024 - Issue
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

36-Month Outcomes of Ahmed ClearPath® Glaucoma Drainage Device in Severe Primary Open Angle Glaucoma

Nithya Boopathiraj1 Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Isabella V Wagner1 Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USAORCID Iconhttps://orcid.org/0000-0001-5386-3692View further author information
ORCID Icon,
Paul Connor Lentz1 Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA;2 Department of Ophthalmology, Mayo Clinic Alix School of Medicine, Jacksonville, FL, USAView further author information
,
Leticia Checo1 Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Emily Aashna Dorairaj3 Department of Medicine, Charles E. Schmidt College of Medicine, Boca Raton, FL, USAORCID Iconhttps://orcid.org/0009-0008-7171-1308View further author information
ORCID Icon,
Abhimanyu S Ahuja4 Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, OR, USAORCID Iconhttps://orcid.org/0000-0003-4333-9189View further author information
ORCID Icon,
Darby D Miller1 Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USAORCID Iconhttps://orcid.org/0000-0003-4920-0970View further author information
ORCID Icon &
Syril Dorairaj1 Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USACorrespondence[email protected]
View further author information
 show all
Pages 1735-1742 | Received 08 Mar 2024, Accepted 12 Jun 2024, Published online: 18 Jun 2024

References

  • Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268
  • Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943–1953. doi:10.1016/s0161-6420(01)00873-9
  • Van Veldhuisen PC, Ederer F, Gaasterland DE, et al. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440.
  • Gedde SJ, Heuer DK, Parrish RK. Tube Versus Trabeculectomy Study G. Review of results from the Tube Versus Trabeculectomy Study. Curr Opin Ophthalmol. 2010;21(2):123–128. doi:10.1097/ICU.0b013e3283360b68
  • Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology. 2007;114(12):2265–2270. doi:10.1016/j.ophtha.2007.02.005
  • Chen PP, Yamamoto T, Sawada A, Parrish RK, Kitazawa Y. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. J Glaucoma. 1997;6(3):192–196. doi:10.1097/00061198-199706000-00010
  • Wilson MR, Mendis U, Paliwal A, Haynatzka V. Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Am J Ophthalmol. 2003;136(3):464–470. doi:10.1016/s0002-9394(03)00239-3
  • Vinod K, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a Survey of the American Glaucoma Society. J Glaucoma. 2017;26(8):687–693. doi:10.1097/IJG.0000000000000720
  • Molteno AC. New implant for drainage in glaucoma. Clinical trial. Br J Ophthalmol. 1969;53(9):606–615. doi:10.1136/bjo.53.9.606
  • Langenberg K, Tran J, Koontz J, Kahook MY. Flow resistance and suture eyelet integrity of the Ahmed ClearPath glaucoma drainage device. Invest Ophth Vis Sci. 2020;61(7):3142.
  • Gedde SJ, Feuer WJ, Lim KS, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology. 2020;127(3):333–345. doi:10.1016/j.ophtha.2019.10.002
  • Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804–814 e1. doi:10.1016/j.ajo.2011.10.024
  • Grover DS, Kahook MY, Seibold LK, et al. Clinical outcomes of Ahmed ClearPath implantation in glaucomatous eyes: a novel valveless glaucoma drainage device. J Glaucoma. 2022;31(5):335–339. doi:10.1097/IJG.0000000000002013
  • Dorairaj S, Checo LA, Wagner IV, Ten Hulzen RD, Ahuja AS. 24-month outcomes of Ahmed ClearPath® glaucoma drainage device for refractory glaucoma. Clin Ophthalmol. 2022;16:2255–2262. doi:10.2147/OPTH.S368634
  • Shalaby WS, Reddy R, Wummer B, et al. Ahmed ClearPath vs baerveldt glaucoma implant: a retrospective noninferiority comparative study. Ophthalmol Glaucoma. 2023. doi:10.1016/j.ogla.2023.12.006

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.